

Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Calcium Dobesilate
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase II
Sponsor : Hervé Spechbach
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Calcium Dobesilate is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of COVID-19.
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
March 31, 2022
Lead Product(s) : Calcium Dobesilate
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II
Sponsor : Hervé Spechbach
Deal Size : Inapplicable
Deal Type : Inapplicable
